BriaCell Therapeutics Corp.
BCTXL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $2.53M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −5 vs. previous quarter
- 10
- 13F valueReported value at the end of Q2 2026
- $2.53M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BCTXL, Q2 2026
No superinvestor reported holding BCTXL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by BriaCell Therapeutics Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 (view filing) | May 14 | 6 daysLate | Lustig MarcDirector, 10% Owner | PPurchase | +902.9K | $2.22 | +$2.00M | +55.1%2.54M after | |
| May 20, 2024 (view filing) | May 14 | 6 daysLate | Lustig MarcDirector, 10% Owner | PPurchase | +902.9K | – | – | –902.9K after | Derivative |
| Dec 28, 2022 (view filing) | Dec 28 | Same day | Bondarenko JamiesonChairman | PPurchase | +28.0K | $4.58 | +$128.2K | +19.7%169.9K after | |
| Dec 28, 2022 (view filing) | Dec 23 | 5 days | Williams William V.President, CEO | PPurchase | +2.53K | $1.94 | +$4.91K | –29.8K after | Derivative |
| Dec 20, 2022 (view filing) | Dec 20 | Same day | Bondarenko JamiesonDirector | PPurchase | +22.0K | $5.35 | +$117.7K | +18.4%141.9K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in BriaCell Therapeutics Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 895,864 | $716.8K | 0.00% | −152,895−14.6% | Reduced |
| Armistice Capital, LLC | 536,600 | $477.6K | 0.01% | 00.0% | Unchanged |
| Cable Car Capital LLC | 321,898 | $286.5K | 0.01% | 00.0% | Unchanged |
| Empery Asset Management, LP | 300,000 | $267.0K | 0.31% | 00.0% | Unchanged |
| MYDA Advisors LLC | 195,821 | $174.3K | 0.04% | −4,179−2.1% | Reduced |
| Sabby Management, LLC | 190,383 | $169.4K | 1.41% | −190,303−50.0% | Reduced |
| Heights Capital Management, Inc | 186,582 | $149.3K | 0.03% | −113,418−37.8% | Reduced |
| Warberg Asset Management LLC | 159,555 | $142.0K | 0.04% | +44,555+38.7% | Added |
| Clear Street Group Inc. | 104,196 | $92.7K | 0.00% | 00.0% | Unchanged |
| Iridian Asset Management LLC | 65,000 | $57.9K | 0.02% | 00.0% | Unchanged |